Skip to main content

UBS Group AG

Position in GRAL — GRAIL, Inc.

CIK 1610520 ZURICH, V8

Position in GRAL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,053,571
+$7,472,462 QoQ
Shares Held
249,796
+34.7% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Jun 30, 2026
CallValue
$771,451
CallShares
11,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,969,656 across 43 Diagnostics & Research names. GRAL ranks #22 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $771,451 11,300
2026-06-30 $17,053,571 249,796
2026-03-31 $9,581,109 185,393
2026-03-31 $583,984 11,300
2025-12-31 $18,245,903 213,178
2025-12-31 $967,167 11,300
2025-09-30 $21,313,761 360,456
2025-06-30 $12,017,779 233,718
2025-03-31 $3,605,097 141,155
2024-12-31 $4,064,764 227,718
2024-09-30 $579,845 42,140
2024-06-30 $811,778 52,816